Viewing Study NCT05073250


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2026-01-05 @ 8:00 PM
Study NCT ID: NCT05073250
Status: UNKNOWN
Last Update Posted: 2023-05-12
First Post: 2021-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module